Cardiometabolic Health

Prevention of Heart Failure With Non-pharmacological Interventions

by Prateek Chopra | May 21, 2026 | Cardiology Conferences | ESC-HF 2026 Heart failure (HF) prevention increasingly focuses on early modification of upstream cardiometabolic risk factors through lifestyle and dietary interventions. Emerging evidence suggests that non-pharmacological strategies targeting hypertension, obesity, diabetes, physical inactivity, and adverse dietary patterns may significantly reduce future HF risk, particularly heart failure with preserved ejection fraction […]

Prevention of Heart Failure With Non-pharmacological Interventions Read Post »

Interventional Treatment of Hypertension: From Renal Denervation to the Next Wave

by Prateek Chopra | June 20, 2026 | Cardiology Conferences | ESH 2026 Therapeutic Context: Renal denervation (RDN) is emerging as a third pillar of hypertension management, alongside lifestyle modification and pharmacotherapy, for selected patients with uncontrolled or resistant hypertension. The clinical question is whether RDN provides benefits beyond BP reduction and whether a single intervention is sufficient for BP control.

Interventional Treatment of Hypertension: From Renal Denervation to the Next Wave Read Post »

Time for Change: Can Lifestyle Interventions Prevent theEvolution of Cardiac Damage in Patients with CKM Syndrome?

by Prateek Chopra | June 2, 2026 | Cardiology Conferences | ESH 2026 Study Objective: Evaluate whether lifestyle interventions can prevent progression of cardiac damage across different stages of CKM syndrome. Evidence Across CKM Stages: Stage 0 (Pre-risk / Children): Stage 2 (Metabolic Risk / Subclinical Disease): Stage 3 (Silent Cardiac Damage): Stage 4 (Established CVD / Secondary Prevention): Clinical Implications

Time for Change: Can Lifestyle Interventions Prevent theEvolution of Cardiac Damage in Patients with CKM Syndrome? Read Post »

Scroll to Top